Chlormadinone Acetate Tab



Indications and Reactions:

Role Indications Reactions
Primary
Prostate Cancer 50.0%
Type 2 Diabetes Mellitus 50.0%
Glucose Tolerance Impaired 100.0%
Secondary
Prostate Cancer 31.1%
Product Used For Unknown Indication 17.5%
Benign Prostatic Hyperplasia 9.7%
Diabetes Mellitus 6.8%
Prostate Cancer Stage Ii 4.9%
Skin Ulcer 3.9%
Urinary Tract Infection 3.9%
Gout 2.9%
Hypertension 2.9%
Carotid Artery Stenosis 1.9%
Depression 1.9%
Gastritis 1.9%
Mental Disorder 1.9%
Prostate Cancer Stage Iii 1.9%
Type 2 Diabetes Mellitus 1.9%
Dysmenorrhoea 1.0%
Gastroenteritis 1.0%
Hormone Replacement Therapy 1.0%
Hypersensitivity 1.0%
Hypertonic Bladder 1.0%
Liver Disorder 21.2%
Diabetes Mellitus 9.1%
Malaise 9.1%
Jaundice 6.1%
Ocular Icterus 6.1%
Pregnancy 6.1%
Abortion Spontaneous 3.0%
Bacteraemia 3.0%
Dermatitis Exfoliative 3.0%
Drug Interaction 3.0%
Dry Mouth 3.0%
Gamma-glutamyltransferase Increased 3.0%
Hepatitis Acute 3.0%
Hyponatraemia 3.0%
Lipids Increased 3.0%
Muscular Weakness 3.0%
Palpitations 3.0%
Pruritus 3.0%
Pyrexia 3.0%
Sepsis 3.0%
Concomitant
Prostate Cancer Stage Iv 40.4%
Product Used For Unknown Indication 7.5%
Prostate Cancer Stage Ii 7.5%
Prostate Cancer 7.4%
Drug Use For Unknown Indication 6.6%
Benign Prostatic Hyperplasia 4.7%
Hypertension 3.8%
Constipation 3.3%
Cancer Pain 2.8%
Gastritis 2.2%
Diabetes Mellitus 1.8%
Pyelonephritis 1.8%
Colon Cancer 1.6%
Metastases To Liver 1.4%
Prostate Cancer Recurrent 1.4%
Urinary Incontinence 1.4%
Lipid Metabolism Disorder 1.2%
Cerebral Infarction 1.1%
Gastric Ulcer 1.1%
Lupus Nephritis 1.1%
Prostate Cancer 17.1%
Prostate Cancer Stage Iv 13.7%
Pneumonia 8.5%
Prostatic Specific Antigen Increased 7.7%
Pleural Effusion 5.1%
Renal Failure Acute 5.1%
Interstitial Lung Disease 4.3%
Cerebral Infarction 3.4%
Chronic Respiratory Failure 3.4%
Death 3.4%
Hypoglycaemia 3.4%
Marasmus 3.4%
Pyrexia 3.4%
Cervix Carcinoma 2.6%
Injection Site Induration 2.6%
Liver Disorder 2.6%
Metastases To Bone 2.6%
Oedema 2.6%
Oedema Peripheral 2.6%
Peritonitis Bacterial 2.6%